Synthesis of optically active tetrahydro-3-benzazepine-2-carboxylic acid derivatives via the ring expansion reaction of isoquinolines and enzymatic resolution

Heterocycles

Volumn 63, Issue 1, 2004, Pages 17-22

  Koseki, Yuji ^a   Ozawa, Hidefumi ^a   Kitahara, Katsuaki ^a   Kato, Ichiro ^a   Sato, Hiroto ^a   Fukaya, Haruhiko ^a   Nagasaka, Tatsuo ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

10B HYDROXYMETHYLOXAZOLOISOQUINOLINE; 3 BENZAZEPINE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; ISOQUINOLINE DERIVATIVE; TETRAHYDRO 3 BENZAZEPINE 2 CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CRYSTAL STRUCTURE; OPTICAL ROTATION; REACTION ANALYSIS; SYNTHESIS;

EID: 0346394080     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-03-9928     Document Type: Article

References (40)

1. For reviews, see: (a) T. Kametani and K. Fukumoto, Heterocycles, 1975, 3, 931.
2. (b) S. Kaspark, 'Advances in Heterocyclic Chemistry' Vol. 39, ed. by A. R. Katritzky, Academic Press, Inc., New York, 1986, p. 45.
3. J. Weinstock, J. P. Hieble, and J. W. Wilson, Drugs Future, 1985, 10, 645.
4. For some recent examples, see: (a) C. N. Haile, G. Carey, G. B. Varty, and V. L. Coffin, Eur. J. Pharmacol., 2000, 388, 125.
5. (b) M. R. Weed, W. L. Woolverton, and I. A. Paul, Eur. J. Pharmacol., 1998, 361, 129.
6. (c) M.-Y. K. Brusniak, R. S. Pearlman, K. A. Neve, and R. E. Wilcox, J. Med. Chem., 1996, 39, 850.
7. (d) H. Wikström, B. Andersson, T. Elebring, and S. Lagerkvist, J. Med. Chem., 1992, 35, 3984.
8. (a) L. Berek, I. B. Petri, E. Varga, J. Molnár, M. Kawase, S. Saito, and N. Motohashi, Int. J. Antimicrob. Agents, 2000, 14, 221.
9. (b) M. Kawase, S. Saito, and N. Motohashi, Int. J. Antimicrob. Agents, 2000, 14, 193.
10. (a) Y. Koseki, S. Kusano, H. Sakata, and T. Nagasaka, Tetrahedron Lett., 1999, 40, 2169.
11. (b) Y. Koseki, S. Katsura, S. Kusano, H. Sakata, H. Sato, Y. Monzen, and T. Nagasaka, Heterocycles, 2003, 59, 527.
12. (c) Y. Koseki, H. Sato, Y. Watanabe, and T. Nagasaka, Org. Lett., 2002, 4, 885.
13. (a) S. E. Gibson, J. O. Jones, R. McCague, M. J. Tozer, and N. J. Whitcombe, Synlett, 1999, 954.
14. (b) S. E. Gibson, N. Guillo, R. J. Middleton, A. Thuilliez, and M. J. Tozer, J. Chem. Soc., Perkin Trans. 1, 1997, 447.
15. The other examples of carboxylic acid or aldehyde derivatives, see: (a) J. R. Fuchs and R. L. Funk, Org. Lett., 2001, 3, 3349.
16. (b) M. Okada, T. Takahashi, M. Yokota, T. Kawasaki, and S. Nagaoka, Jpn. Kokai Tokkyo Koho JP 02,193,971, 1990 (Chem. Abstr., 1990, 114, 81626).
17. (c) D. Ben-Ishai, I. Sataty, N. Peled, and R. Goldshare, Tetrahedron, 1987, 43, 439.
18. (d) H. Bieräugel, H.-P. Soetens, and U. K. Pandit, Heterocycles, 1977, 7, 37.
19. (e) O. Yonemitsu, T. Tokuyama, M. Chaykovsky, and B. Witkop, J. Am. Chem. Soc., 1968, 90, 776.
20. (f) K. Dimroth and H. Freyschlag, Chem. Ber., 1956, 89, 2602.
21. (a) S. E. Gibson, N. Guillo, J. O. Jones, I. M. Buck, S. B. Kalindjian, S. Roberts, and M. J. Tozer, Eur. J. Med. Chem., 2002, 37, 379.
22. (b) S. E. Gibson, N. Guillo, S. B. Kalindjian, and M. J. Tozer, Bioorg. Med. Chem. Lett., 1997, 7, 1289.
23. For reviews, see: Ref. 1a. For recent some references not included in the above review, see: Ref. 5b; and references cited therein.
24. A. Padwa, L. S. Beall, C. K. Eidell, and K. J. Worsencroft, J. Org. Chem., 2001, 66, 2414.
25. 4a,b were prepared as follows. Compound (4a): Treatment of propargyl 2-(3,4-dimethoxyphenyl)ethylcarbamate with LiN(TMS)2 (0.3 equiv.) in THF at 66 °C afforded 4a in 90% yield. Compound (4b): Treatment of 3-phenylprop-2-ynyl 2-(3,4-dimethoxyphenyl)ethylcarbamate with NaN(TMS)2 (0.3 equiv.) in the presence of 18-crown-6 (0.3 equiv.) in toluene at 60 °C afforded 4b in 97% yield. And also, see: Y. Tamaru, M. Kimura, S. Tanaka, S. Kure, and Z. Yoshida, Bull. Chem. Soc. Jpn., 1994, 67, 2838; and references cited therein.
26. Y. Koseki, S. Kusano, D. Ich, K. Yoshida, and T. Nagasaka, Tetrahedron, 2000, 56, 8855.
27. For the first example of oxidation of ethylidenetetrahydro-1,3-oxazin-2-one with MCPBA, see: T. G. Back, O. E. Edwards, and G. A. MacAlpine, Tetrahedron Lett., 1977, 2651.
28. For some examples of similar cyclization to oxazolo- or thiazoloisoquinolines, see: (a) I. Osante, M. I. Collado, E. Lete, and N. Sotomayor, Eur. J. Org. Chem., 2001, 1267.
29. (b) M. I. Collado, N. Sotomayor, M.-J. Villa, and E. Lete, Tetrahedron Lett., 1996, 37, 6193.
30. The synthesis of 3a has been reported, see: M. Bois-Choussy, S. Cadet, M. D. Paolis, and J. Zhu, Tetrahedron Lett., 2001, 42, 4503.
31. 3, followed by a conventional work-up. The residue was chromatographed (silica gel, hexane-AcOEt = 10: 1) to give 2a (9.9 g) in 85% yield.
32. 5: C, 67.90; H, 6.78; N; 3.77. Found: C, 67.79; H, 6.78; N, 3.70.
33. For an example of low-temperature method in the kinetic resolution, see: T. Sakai, T. Kishimoto, Y. Tanaka, T. Ema, and M. Utaka, Tetrahedron Lett., 1998, 39, 7881.
34. N. Langlois and F. Rakotondradany, Tetrahedron, 2000, 56, 2437.
35. M. Zhao, J. Li, E. Mano, Z. Song, D. M. Tschaen, E. J. J. Grabowski, and P. J. Reider, J. Org. Chem., 1999, 64, 2564.
36. +) 386.1604, found 386.1601.
37. 2O) δ: 31.38, 34.69, 45.49, 56.52, 56.58, 58.52, 113.9, 114.8, 129.4, 132.6, 147.4, 147.8, 171.5.
38. 3, all diagrams and calculations were performed using maXus crystallographic software package, the refinement was performed using SHELX-97.
39. a) S. Mackay, C. J. Gilmore, C. Edwards, N. Stewart, and K. Shankland, maXus Computer Program for the Solution and Refinement of Crystal Structures. Bruker Nonius, The Netherlands, MacScience, Japan and The University of Glasgow, 1999.
40. G. M. Sheldrick, SHELXL-97, Program for The Crystal Structure Refinement, University of Göttingen, Germany, 1997.